학력

학력
- (학사) 인제대학교 임상병리학과
- (석사) 인제대학교 식의약생명공학과
- (박사) 인제대학교 식의약생명공학과

교육 및 연구경력

-2014.02 ~ 2021.08 국립암센터 연구소 종양면역학연구과 (박사후연구원) 
-2021.09 ~ 2024.02 가톨릭관동대학교 임상병리학과 (조교수)
-2024.03 ~ 현재 인제대학교 임상병리학과 (조교수)

기타 및 학술관련 경력

- 정회원, 대한면역학회
- 정회원, European Society for Medical Oncology
- 정회원, 대한의생명과학회

연구 관심 분야

- 항암 세포치료제 개발 
- 면역치료제 효능 향상을 위한 전임상 연구

강의 분야

- 면역학, 면역혈청학 및 실험, 임상면역학
- 해부학, 해부생리학

저서 및 주요 논문

1. Kim SH, Go EM, Shin DH, Choi BK, Han C. Pro- and Anti-Tumoral Factors Involved in Total Body Irradiation and Interleukin-2 Conditioning in Adoptive T Cell Therapy of Melanoma-Bearing Rag1 Knock-Out Mice. Cells. 2022 Dec 2;11(23):3894.
2. Kim SH, Cho E, Kim YI, Han C, Choi BK, Kwon BS. Adoptive immunotherapy with transient anti-CD4 treatment enhances anti-tumor response by increasing IL-18Rαhi CD8+ T cells. Nat Commun. 2021 Sep 7;12(1):5314. 
3. Kim SH*, Singh R*, Han C, Cho E, Kim YI, Lee DG, Kim YH, Kim SS, Shin DH, You HJ, Lee HW, Kwon BS, Choi BK. Chronic activation of 4-1BB signaling induces granuloma development in tumor-draining lymph nodes that is detrimental to subsequent CD8+ T cell responses. Cell Mol Immunol. 2021 Aug;18(8):1956-1968. 
4. Han C*, Choi BK*, Kim SH*, Sim SJ, Han S, Park B, Tsuchiya Y, Takahashi M, Kim YH, Eom HS, Kitaguchi T, Ueda H, Kwon BS. Polymorphic Region-Specific Antibody for Evaluation of Affinity-Associated Profile of Chimeric Antigen Receptor. Mol Ther Oncolytics. 2020 Apr 14;17:293-305.
5. Cho E, Singh R, Han C, Kim SH, Kim KH, Park BM, Shin DH, Han S, Kim YH, Kwon BS, Nam KT, Choi BK. 4-1BB-4-1BBL cis-interaction contributes to the survival of self-reactive CD8+ T cell. Cell Mol Immunol. 2023 Sep;20(9):1077-1080.
6. Yu EM, Cho E, Singh R, Kim SH, Han C, Han S, Lee DG, Kim YH, Kwon BS, Choi BK. IL7-Fc Enhances the Efficacy of Adoptive T Cell Therapy under Lymphopenic Conditions in a Murine Melanoma Model. Cells. 2021 Aug 7;10(8):2018